Mirae Asset Healthcare Fund

Direct · Growth

AI Summary

Performance

Mirae Asset Healthcare Fund has delivered strong SIP XIRR across all horizons, with 1Y at 26.16%, 3Y at 23.71%, 5Y at 22.26%, and 7Y at 21.84%. These returns comfortably outpace the category average SIP XIRR at every comparable period, beating the 1Y category average of 15.91% by over 10 percentage points and the 7Y average of 18.51% by over 3 percentage points. The consistent outperformance across multiple timeframes suggests durable stock selection rather than a short-term rally.

Risk

The fund shows a maximum drawdown of just -0.20% over the measured period with a quick 16-day recovery, though it has experienced 4 drawdown events exceeding 10%, reflecting the inherent volatility of the healthcare theme. Calendar year returns reveal meaningful volatility, ranging from +76.23% in 2020 to -10.61% in 2022 and -2.4% in 2025. Calmar ratios above 1.15 across all horizons (1.26 at 1Y, 1.16 at 7Y) indicate solid risk-adjusted returns relative to drawdowns.

Portfolio

Portfolio composition data was not provided in this analysis, so specific top holdings and sector weights cannot be assessed. As a healthcare thematic fund, it is inherently concentrated in the pharmaceutical, healthcare, and diagnostics sectors, which limits diversification relative to diversified equity funds. Investors should review the current factsheet for holding-level detail before investing.

Category Positioning

The fund outperforms the category average SIP XIRR at every measured horizon, with the widest gap at 1Y (26.16% vs 15.91%) and a meaningful lead at 3Y (23.71% vs 17.72%) and 5Y (22.26% vs 17.04%). Rolling returns are tightly clustered between 23.14% and 25.15% across 1Y to 7Y windows, indicating strong consistency in lump-sum performance as well. This persistent edge over peers across both SIP and rolling return measures points to sustained competitive positioning within the thematic healthcare category.

Investor Suitability

This fund suits investors seeking targeted exposure to the healthcare and pharma theme as a satellite holding within a broader diversified portfolio, not as a core holding. A horizon of at least 5-7 years is advisable given the theme's cyclicality, as seen in negative calendar year returns in 2022 and 2025. Investors should have a high risk tolerance for sector concentration and be prepared for periods of significant underperformance versus diversified funds.

  • Consistent outperformance versus category average SIP XIRR across all horizons, including 26.16% 1Y XIRR versus the category's 15.91%
  • Strong risk-adjusted returns with Calmar ratios above 1.15 across 1Y to 7Y periods
  • Low expense ratio of 0.51% for a thematic fund, which helps preserve net returns

  • Thematic concentration in healthcare exposes investors to sector-specific downturns, as evidenced by -10.61% in 2022 and -2.4% in 2025
  • Four drawdown events exceeding 10% indicate the fund can experience substantial interim losses despite recent low maximum drawdown readings

Generated on 06-09-2026, 7:50 PM. Verify before investing.

₹51.60
18 Aug 2026
NAV
23.8%
3Y CAGR
23.4%
5Y CAGR
23.5%
Weighted CAGR
?
3.19
Sharpe
-20.0%
Max Drawdown
?
0.51%
TER

If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.

Duration Invested Median Value XIRR Min XIRR Max XIRR
1 Year ₹12.00 L ₹13.12 L 26.2% -26.4% 112.8%
3 Years ₹36.00 L ₹48.84 L 23.7% 2.0% 48.5%
5 Years ₹60.00 L ₹1.01 Cr 22.3% 14.4% 31.0%
7 Years ₹84.00 L ₹1.81 Cr 21.8% 18.8% 24.8%

SIP returns vs benchmark & category

Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.

Duration Fund SIP XIRR Category avg
1 Year 26.2% 15.9%
3 Years 23.7% 17.7%
5 Years 22.3% 17.0%
7 Years 21.8% 18.5%

Duration Mean Median Min Max Sharpe Sortino % Positive Cat. Mean Cat. Median
1 Year 25.1% 19.1% -11.1% 93.0% 0.75 3.48 82%
3 Years 23.8% 23.3% 14.3% 35.8% 3.11 100%
5 Years 23.4% 23.6% 15.4% 34.3% 3.19 100%

-20.0%
Max Drawdown
1 mo
Drawdown Duration
1 mo
Recovery Time
-4.7%
Avg Drawdown

Calmar Ratio by Duration

1.26
1Y
1.19
3Y
1.17
5Y
1.16
7Y